Dementia is not a specific disease. It’s an umbrella term for a range of conditions that cause progressive decline in memory, thinking, and daily functioning. Alzheimer’s disease is one specific type of dementia, and the most common one, accounting for 60% to 80% of all dementia cases. Think of it this way: all Alzheimer’s is dementia, but not all dementia is Alzheimer’s.
The confusion between the two terms is understandable. Doctors, media, and even family members use them interchangeably. But the distinction matters because different types of dementia have different causes, different symptoms, different progression patterns, and increasingly different treatments.
What Makes Alzheimer’s Distinct
Alzheimer’s disease is caused by two specific abnormalities in the brain: amyloid plaques and neurofibrillary tangles. Amyloid plaques are clumps of a protein called beta amyloid that build up in the tissue between nerve cells. Neurofibrillary tangles form inside neurons when a protein called tau twists into abnormal shapes. In a healthy brain, tau helps maintain the internal transport system that delivers nutrients through nerve cells. In Alzheimer’s, the damaged tau causes that transport system to collapse, cutting off communication between neurons and eventually killing them.
This process is slow and progressive. Alzheimer’s typically moves through three broad stages: early (mild), middle (moderate), and late (severe). In the early stage, a person can still function independently, drive, and work, though they may notice memory lapses like forgetting familiar words or misplacing everyday objects. The middle stage is usually the longest, lasting many years, and brings more pronounced symptoms: confusing words, getting frustrated or angry, and needing increasing help with routine tasks. In the late stage, individuals lose the ability to carry on conversations, respond to their environment, and eventually control movement. On average, a person with Alzheimer’s lives four to eight years after diagnosis, though some live as long as 20 years.
Other Types of Dementia
Because dementia is an umbrella term, it covers several distinct conditions beyond Alzheimer’s, each with its own pattern of symptoms and underlying cause.
Vascular dementia results from reduced blood flow to the brain, often after strokes or damage to blood vessels. Rather than the slow, steady decline seen in Alzheimer’s, vascular dementia often progresses in noticeable steps, with sudden drops in ability following each vascular event. The most prominent early symptoms tend to involve difficulty with planning, organizing, and making decisions rather than memory loss.
Lewy body dementia has a distinctive profile that sets it apart. Visual hallucinations, seeing shapes, animals, or people that aren’t there, are often one of the first symptoms. People with this type also develop movement problems similar to Parkinson’s disease: slowed movement, rigid muscles, tremor, and a shuffling walk. Sleep disturbances are common, particularly a condition where people physically act out their dreams, punching, kicking, or yelling while asleep. Fluctuating attention, with episodes of drowsiness, long staring spells, or disorganized speech, is another hallmark.
Frontotemporal dementia tends to appear at a younger age than Alzheimer’s and primarily affects personality, behavior, and language rather than memory. Someone with this type might become socially inappropriate, impulsive, or emotionally flat in ways that seem completely out of character.
Some Dementia Symptoms Are Reversible
One of the most important reasons to get a proper diagnosis rather than assuming “it’s just dementia” is that several treatable conditions can mimic dementia symptoms. Depression can make a person seem confused, withdrawn, and forgetful. Vitamin deficiencies, particularly B-12 and folate, affect brain function. Medication interactions, especially in older adults taking multiple prescriptions, can cause confusion and memory problems. Infections like syphilis and Lyme disease have been known to cause dementia-like symptoms. Even poor nutrition and low blood sugar can impair thinking.
Unlike Alzheimer’s, these causes can be cured with the right treatment. This is why a thorough evaluation matters so much, not just to identify the type of dementia, but to rule out conditions that might be entirely fixable.
How Doctors Tell Them Apart
There’s no single test that diagnoses dementia or identifies its type. Doctors use a combination of cognitive assessments, brain imaging, and increasingly, biomarker tests to narrow down the cause.
CT scans and MRIs produce detailed images of the brain and can rule out tumors, strokes, and head injuries. MRIs can also reveal shrinkage in brain regions associated with Alzheimer’s. A specialized scan called FDG PET shows areas of the brain where nutrients aren’t being properly used for energy, and the patterns of low metabolism help distinguish Alzheimer’s from other dementia types. Newer imaging tests can directly detect amyloid plaques and tau tangles in the brain.
Blood tests have become increasingly useful. Recent advances mean that levels of beta-amyloid and tau proteins can now be measured in blood, providing a less invasive way to determine whether Alzheimer’s-related changes are present in the brain. These proteins can also be measured in cerebrospinal fluid, the liquid surrounding the brain and spinal cord. Together, these biomarker tests allow doctors to diagnose Alzheimer’s during life with far more certainty than was possible even a few years ago.
Why the Distinction Matters for Treatment
General dementia management has long focused on symptom relief: medications to temporarily improve memory and thinking, strategies to maintain daily function, and support for caregivers. But an accurate Alzheimer’s diagnosis now opens the door to disease-specific therapies that target the underlying biology.
The FDA has approved treatments that work by clearing amyloid plaques from the brain. One of the most recent, donanemab, was shown in clinical trials to significantly slow cognitive and functional decline compared to placebo over 76 weeks. These treatments are specifically for people with Alzheimer’s in the early stages, those with mild cognitive impairment or mild dementia, and they require confirmed amyloid buildup in the brain before starting. They also carry risks, including temporary brain swelling and small spots of bleeding, which require monitoring with brain scans during treatment. Genetic testing is recommended beforehand because people with certain gene variants face higher risk of these side effects.
None of these Alzheimer’s-specific treatments would be appropriate for someone whose dementia is caused by blood vessel damage or Lewy bodies. A person with vascular dementia benefits most from managing cardiovascular risk factors. Someone with Lewy body dementia may need careful medication management because they can react severely to certain drugs commonly used for other types. The underlying cause shapes everything about how dementia is treated, which is exactly why knowing the difference between “dementia” and “Alzheimer’s” is more than a vocabulary question.